Avacta Group plc (GB:AVCT) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Avacta Group plc, a life sciences company specializing in cancer treatments and diagnostics, will unveil its unaudited interim results for the first half of 2024 on September 30. Shareholders and potential investors are invited to attend an online presentation by CEO Christina Coughlin on the same day, where they can submit questions and engage with the company’s progress. The results and presentation will also be accessible on Avacta’s website, highlighting their proprietary platforms aimed at optimizing cancer drug delivery.
For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.
